Lipocine Inc (LPCN)
5.40
-0.03
(-0.55%)
USD |
NASDAQ |
Apr 19, 16:00
5.40
0.00 (0.00%)
After-Hours: 17:16
Lipocine Free Cash Flow (Quarterly): -2.032M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -2.032M |
| September 30, 2023 | -2.606M |
| June 30, 2023 | -3.310M |
| March 31, 2023 | -3.932M |
| December 31, 2022 | -1.936M |
| September 30, 2022 | -3.198M |
| June 30, 2022 | -3.057M |
| March 31, 2022 | -3.912M |
| December 31, 2021 | 8.994M |
| September 30, 2021 | -6.981M |
| June 30, 2021 | -2.363M |
| March 31, 2021 | -4.062M |
| December 31, 2020 | -3.684M |
| September 30, 2020 | -4.164M |
| June 30, 2020 | -4.079M |
| March 31, 2020 | -3.376M |
| December 31, 2019 | -3.308M |
| September 30, 2019 | -2.797M |
| June 30, 2019 | -2.558M |
| March 31, 2019 | -3.003M |
| December 31, 2018 | -2.233M |
| September 30, 2018 | -3.360M |
| June 30, 2018 | -2.740M |
| March 31, 2018 | -3.746M |
| Date | Value |
|---|---|
| December 31, 2017 | -4.297M |
| September 30, 2017 | -4.566M |
| June 30, 2017 | -4.701M |
| March 31, 2017 | -3.139M |
| December 31, 2016 | -2.547M |
| September 30, 2016 | -4.050M |
| June 30, 2016 | -5.197M |
| March 31, 2016 | -6.548M |
| December 31, 2015 | -2.912M |
| September 30, 2015 | -5.572M |
| June 30, 2015 | -3.863M |
| March 31, 2015 | -3.038M |
| December 31, 2014 | -4.001M |
| September 30, 2014 | -2.497M |
| June 30, 2014 | -7.646M |
| March 31, 2014 | -3.220M |
| December 31, 2013 | -4.113M |
| September 30, 2013 | -4.476M |
| June 30, 2013 | -0.0004M |
| March 31, 2013 | -0.0001M |
| December 31, 2012 | 2.088M |
| September 30, 2012 | -2.091M |
| June 30, 2012 | -0.055M |
| March 31, 2012 | -0.0051M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-6.981M
Minimum
Sep 2021
8.994M
Maximum
Dec 2021
-2.756M
Average
-3.308M
Median
Dec 2019
Free Cash Flow (Quarterly) Benchmarks
| Alpine Immune Sciences Inc | -19.08M |
| NeuroBo Pharmaceuticals Inc | -3.402M |
| Eliem Therapeutics Inc | -0.947M |
| NovaBay Pharmaceuticals Inc | -0.316M |
| Palatin Technologies Inc | -10.51M |